NZ709094A - Pyrimidine-2,4-diamine derivatives for treatment of cancer - Google Patents
Pyrimidine-2,4-diamine derivatives for treatment of cancerInfo
- Publication number
- NZ709094A NZ709094A NZ70909413A NZ70909413A NZ709094A NZ 709094 A NZ709094 A NZ 709094A NZ 70909413 A NZ70909413 A NZ 70909413A NZ 70909413 A NZ70909413 A NZ 70909413A NZ 709094 A NZ709094 A NZ 709094A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cancer
- treatment
- pyrimidine
- diamine derivatives
- compound
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical class NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101000744394 Homo sapiens Oxidized purine nucleoside triphosphate hydrolase Proteins 0.000 abstract 1
- 102100039792 Oxidized purine nucleoside triphosphate hydrolase Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261797022P | 2012-11-27 | 2012-11-27 | |
| SE1251332 | 2012-11-27 | ||
| PCT/SE2013/051387 WO2014084778A1 (en) | 2012-11-27 | 2013-11-26 | Pyrimidine-2,4-diamine derivatives for treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ709094A true NZ709094A (en) | 2019-10-25 |
Family
ID=68318672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ70909413A NZ709094A (en) | 2012-11-27 | 2013-11-26 | Pyrimidine-2,4-diamine derivatives for treatment of cancer |
Country Status (5)
| Country | Link |
|---|---|
| DK (1) | DK2925744T3 (en) |
| ES (1) | ES2860937T3 (en) |
| NZ (1) | NZ709094A (en) |
| PT (1) | PT2925744T (en) |
| SA (1) | SA515360493B1 (en) |
-
2013
- 2013-11-26 DK DK13859400.7T patent/DK2925744T3/en active
- 2013-11-26 ES ES13859400T patent/ES2860937T3/en active Active
- 2013-11-26 NZ NZ70909413A patent/NZ709094A/en unknown
- 2013-11-26 PT PT138594007T patent/PT2925744T/en unknown
-
2015
- 2015-05-27 SA SA515360493A patent/SA515360493B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2925744T3 (en) | 2021-03-15 |
| SA515360493B1 (en) | 2017-12-27 |
| ES2860937T3 (en) | 2021-10-05 |
| PT2925744T (en) | 2021-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501058A1 (en) | Pyrimidine-2,4-diamine derivatives for treatment of cancer | |
| PH12019501321A1 (en) | Methods of treating or preventing cholesterol related disorders | |
| MX2014005928A (en) | Heterocyclic inhibitors of glutaminase. | |
| MX2018000396A (en) | Substituted aza compounds as irak-4 inhibitors. | |
| MY202022A (en) | Pyrrolotriazine compounds as tam inhibitors | |
| BR112015000399A2 (en) | pyrazolyl pyrimidine derivatives | |
| PH12019500480A1 (en) | Pyridine compound | |
| SA515360469B1 (en) | Heterocyclic compounds for inhibiting glutaminase and their methods of use | |
| MD4659B1 (en) | Polymorph of SYK inhibitors | |
| NI201800042A (en) | NEW DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE AS DUAL INHIBITORS OF DYRK1 / CLK1 | |
| PH12016500225B1 (en) | Novel quinoline-substituted compound | |
| MD4684B1 (en) | Imidazopyrazine-based formulations as SYK inhibitors | |
| EA201690020A1 (en) | APPLICATION OF PYRAZOLOPIRIDINE DERIVATIVES FOR THE TREATMENT OF URINARY BUBBLE CANCER | |
| NZ626618A (en) | Hydroxamic acid derivatives and uses thereof | |
| UA111382C2 (en) | Protein kinase inhibitors | |
| MX2015014298A (en) | Dihydropyrido pyrimidine compounds as autotaxin inhibitors. | |
| EA201591301A1 (en) | NEW PYRIMIDINE AND PYRIDINE CONNECTIONS AND THEIR APPLICATION | |
| PH12015502611A1 (en) | Heterocyclic compounds as hedgehog signaling pathway inhibitors | |
| MX351863B (en) | Quinolylpyrrolopyrimidyl fused-ring compound or salt thereof. | |
| TN2012000469A1 (en) | Use of novel pan-cdk inhibitors for treating tumors | |
| MX357763B (en) | Treatment for pancreatic cancer. | |
| PH12016500735A1 (en) | Substituted pyrimidine compounds and their use as syk inhibitors | |
| PH12017500492A1 (en) | Crystalline bace inhibitors | |
| PH12016500809A1 (en) | Glucopyranosyl - substituted indole-urea derivatives and their use as sglt inhibitors | |
| NZ709094A (en) | Pyrimidine-2,4-diamine derivatives for treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 NOV 2021 BY CPA GLOBAL (PATRAFEE) AB Effective date: 20201028 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 NOV 2022 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE Effective date: 20211102 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 NOV 2023 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE Effective date: 20221110 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 NOV 2024 BY CPA GLOBAL (PATRAFEE) AB Effective date: 20231031 |